Long-Term Liabilities (Annual)

Long-Term Liabilities: The sum of all non-current liabilities.

Surgery Partners, Inc. (SGRY) had Long-Term Liabilities of $3.32B for the most recently reported fiscal year, ending 2023-12-31.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$2.74B
Net Income	$-11.90M
Cost of Goods Sold	$2.10B
Gross Profit	$647.50M
Operating Expenses	$2.42B
Operating Income	$328.00M
Non-Operating Income/Expense	$-193.00M
Pre-Tax Income	$135.00M
Normalized Pre-Tax Income	$135.00M
Income after Taxes	$135.30M
Income from Continuous Operations	$135.30M
Consolidated Net Income/Loss	$135.30M
Normalized Income after Taxes	$135.30M
EBIT	$342.20M
EBITDA	$460.30M
Weighted-Average Shares Outstanding (Basic)	125.61M
Weighted-Average Shares Outstanding (Diluted)	125.61M
Earnings per Share (EPS) (Basic)	$-0.09
Earnings per Share (EPS) (Diluted)	$-0.09
Balance Sheet Financials
Current Assets	$895.00M
Property, Plant, and Equipment	$968.70M
Long-Term Assets	$5.98B
Total Assets	$6.88B
Current Liabilities	$523.00M
Long-Term Debt	$2.70B
Long-Term Liabilities	$3.32B
Total Liabilities	$3.84B
Common Equity	$3.03B
Tangible Shareholders Equity	$-1.35B
Shareholders Equity	$3.03B
Common Shares Outstanding	126.59M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$293.80M
Cash Flow from Investing Activities	$-225.60M
Cash Flow from Financial Activities	$-155.20M
Beginning Cash	$282.90M
End Cash	$195.90M
Increase/Decrease in Cash	$-87.00M
Stock-Based Compensation	$17.70M
Common Stock Dividends Paid	$-146.10M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.71
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.47
Debt to Equity Ratio	0.91
Gross Margin	23.60%
Operating Margin	11.96%
EBIT Margin	12.47%
EBITDA Margin	16.78%
Pre-Tax Profit Margin	4.92%
Profit Margin	-0.43%
Free Cash Flow	$230.80M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.40
Inventory Turnover	27.87
Receiveable Turnover	5.53
Days Sales in Receivables	66.05
Return on Equity	4.46%
Return on Tangible Equity	-10.05%
Return on Assets	1.97%
Return on Investments	2.36%
Book Value Per Share	$23.97
Free Cash Flow per Share	$1.84
Operating Cash Flow per Share	$2.34

Data from Zacks Investment Research, Inc.